The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease

  title={The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease},
  author={D. Tran and Dan Palfrey and R. Welsh},
  journal={PharmacoEconomics - Open},
  pages={1 - 11}
  • D. Tran, Dan Palfrey, R. Welsh
  • Published 2021
  • Medicine
  • PharmacoEconomics - Open
  • We calculated the short- and long-term care resource use and costs in adults with high-risk conditions for cardiovascular disease (HRCVD) as defined by the Canadian Cardiovascular Society dyslipidemia guidelines. We linked Alberta health databases to identify patients aged ≥ 18 years with HRCVD between fiscal year (FY) 2012 and FY2016. The first HRCVD event was the index event. Patients were categorized into (1) primary prevention patients and (2) secondary prevention patients at the index… CONTINUE READING

    Figures and Tables from this paper


    Outcome and Cost of Optimal Control of Dyslipidemia in Adults With High Risk for Cardiovascular Disease.
    • 1
    • Highly Influential
    2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.
    • 478
    • Highly Influential
    • PDF
    Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta.
    • 11
    The Healthcare Cost Burden of Acute Myocardial Infarction in Alberta, Canada
    • 11
    • PDF
    Economic burden of cardiovascular diseases in the enlarged European Union.
    • 643
    • PDF
    The Impact of Prevention on Reducing the Burden of Cardiovascular Disease
    • 169
    • PDF
    Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association
    • 1,527